These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2318247

  • 1. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity.
    Lider O, Mekori YA, Miller T, Bar-Tana R, Vlodavsky I, Baharav E, Cohen IR, Naparstek Y.
    Eur J Immunol; 1990 Mar; 20(3):493-9. PubMed ID: 2318247
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N, Disatnik MH, Nevo Z.
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
    Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z.
    Invasion Metastasis; 1992 Jan; 12(2):112-27. PubMed ID: 1399400
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
    Vlodavsky I, Mohsen M, Lider O, Svahn CM, Ekre HP, Vigoda M, Ishai-Michaeli R, Peretz T.
    Invasion Metastasis; 1992 Jan; 14(1-6):290-302. PubMed ID: 7657522
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity.
    Van Loveren H, Kato K, Meade R, Green DR, Horowitz M, Ptak W, Askenase PW.
    J Immunol; 1984 Nov; 133(5):2402-11. PubMed ID: 6332850
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.
    Lider O, Baharav E, Mekori YA, Miller T, Naparstek Y, Vlodavsky I, Cohen IR.
    J Clin Invest; 1989 Mar; 83(3):752-6. PubMed ID: 2493485
    [Abstract] [Full Text] [Related]

  • 14. Site-selective homing of antigen-primed lymphocyte populations can play a crucial role in the efferent limb of cell-mediated immune responses in vivo.
    Spangrude GJ, Araneo BA, Daynes RA.
    J Immunol; 1985 May; 134(5):2900-7. PubMed ID: 4038988
    [Abstract] [Full Text] [Related]

  • 15. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo.
    Zhu YN, Zhao WM, Yang YF, Liu QF, Zhou Y, Tian J, Ni J, Fu YF, Zhong XG, Tang W, Zhou R, He PL, Li XY, Zuo JP.
    J Pharmacol Exp Ther; 2006 Feb; 316(2):662-9. PubMed ID: 16204471
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix.
    Eldor A, Bar-Ner M, Yahalom J, Fuks Z, Vlodavsky I.
    Semin Thromb Hemost; 1987 Oct; 13(4):475-88. PubMed ID: 3321438
    [Abstract] [Full Text] [Related]

  • 19. The in vivo behavior of T cell clones: altered migration due to loss of the lymphocyte surface homing receptor.
    Dailey MO, Gallatin WM, Weissman IL.
    J Mol Cell Immunol; 1985 Oct; 2(1):27-36. PubMed ID: 2978224
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.